Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features

Cell Cycle
Jenny PaupertCatherine Muller

Abstract

The metalloprotease 9 (MMP-9), a known mediator of tumour invasion, is secreted as a 92 kDa pro-form but a non-secreted variant of 85 Kda has been described. The importance of this variant pro-form in tumor progression remains poorly defined. We previously showed that the DNA repair protein Ku interacts at the cell surface of leukaemia cell lines with the 85 Kda pro-form of MMP-9 and these Ku/MMP-9 complexes regulates cell invasion, highlighting their importance in haematological malignancies. We demonstrate here that all samples of acute myeloid leukaemia (AML) blasts purified from bone marrow of 16 affected patients express the 85 Kda form of MMP-9. However, only AML that display monocytic lineage markers (AML4/5) express this form at the cell surface with co-expression of the membrane associated form of Ku. Blocking antibodies directed against Ku or MMP-9 specifically inhibited cell invasion of those expressing Ku/MMP-9 on the cell surface. The membrane form of Ku might represent an important factor in the exposition to the cell surface of this specific MMP-9 pro-form in AML with monocytic features. These results might have important functional significance in the occurrence of extra-medullar infiltrates of leukaemia cells t...Continue Reading

Citations

Jan 30, 2014·Cancers·Antonietta Rosella Farina, Andrew Reay Mackay
Jan 5, 2014·Molecular and Cellular Biochemistry·Xishan ZhuGang Liu
Apr 4, 2013·Critical Reviews in Biochemistry and Molecular Biology·Jennifer VandoorenGhislain Opdenakker
Oct 23, 2012·Experimental Hematology·Teresa BernalAna Gutiérrez-Fernández
Dec 3, 2010·Experimental and Molecular Pathology·Hui-Yuan ShaoLing Zhang
Oct 15, 2013·Journal of Cellular Physiology·Wen-Hsin LiuLong-Sen Chang
Apr 11, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Fon-Chang LiuChieh-Hsi Wu
Nov 30, 2010·Biochimica Et Biophysica Acta·Aude GrigolettoJean Rosenbaum
Mar 18, 2015·Blood·Christoph Röllig, Gerhard Ehninger
Jan 30, 2016·American Journal of Hematology·Paolo BernasconiCeleste Calvello
Oct 12, 2021·Transfusion·Dawn MazeLani Lieberman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.